Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 04 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-04-2022-6

Zydus Lifesciences Limited has informed the Exchange about press release dated 04-Aug-2022 titled Zydus receives final approval from the USFDA for Ivermectin Cream and Zydus receives final approval from the USFDA for Empagliflozin Tablets

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases